X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    FDA Accepts BLA for Recommended

    FDA Accepts BLA for Recommended Biosimilar to Simponi

    Merck to Acquire Verona

    Merck to Acquire Verona Pharma in $10B Deal Boosts COPD Drug

    Emerging Oral Small Molecule Drugs

    Emerging Oral Small-Molecule Drugs for Ultra-Rare Diseases

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    FDA Accepts BLA for Recommended

    FDA Accepts BLA for Recommended Biosimilar to Simponi

    Merck to Acquire Verona

    Merck to Acquire Verona Pharma in $10B Deal Boosts COPD Drug

    Emerging Oral Small Molecule Drugs

    Emerging Oral Small-Molecule Drugs for Ultra-Rare Diseases

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Americas

JSS and iMedrix Announce Formation of Innovation Centre in Connected Cardiac Care

Content Team by Content Team
8th January 2018
in Americas, News

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

JSS University, one of the premier medical sciences universities in India and iMedrix, a pioneer in mHealth, announced the formation of an Innovation Centre in Connected Cardiac Care at the University’s main campus in Mysore.

Given the rate at which the epidemic of Cardio Vascular Diseases and life style diseases is spreading, this Centre will focus on an integrated, multi-disciplinary approach to the early detection, prevention, acute care and follow up of heart diseases and related co-morbidities such as obesity, diabetes, hypertension and abnormal lipid profiles.

The Centre will pioneer advanced use models of iMedrix’s revolutionary KardioScreen technology, through which asymptomatic, symptomatic and acute care patients will be evaluated to identify abnormalities requiring further treatment. This process will bring new protocols and provide more insights into the cardiac care for both individuals and for community. Patients no longer need to travel to a hospital for a check-up – Connected Cardiac Care brings the advice of medical experts to their doorstep. Patients requiring follow up will be given appointments to visit the facility and receive integrated multi-disciplinary treatment across Cardiology, Emergency, Nephrology, Endocrinology, Ophthalmology and Podiatry plus nutrition and wellness guidance. Post-operative patients can also reduce or avoid follow-up visits using the connected care model.

“Acting early in Cardio Vascular disease development is essential to preventing an early death and extending life,” said Prof. (Dr.) Nagaraj Desai, renowned Cardiologist, who has mentored the formation of the Centre. “Connected Cardiac Care from this Centre will benefit 1000s of patients and save many lives by timely intervention. Integrated care means that the patient gets comprehensive advice in a single visit.”

“The advent of digital, connected technologies in medicine holds immense potential. JSS University is pleased to have formed a first of its kind Centre in India,” Dr. B.N.Suresh, Vice Chancellor of JSS University, “We will pioneer new models of integrated and affordable, preventive and predictive cardiac care for the population of this region.”

“iMedrix is pleased to be a part of this Centre and contribute our unique cloud enhanced mobile Cardiac care solution,” said Srikanth Jadcherla, Chairman of iMedrix, “We are fortunate to drive the next wave of innovation in mHealth under the guidance of renowned medical experts at JSS, making health care mobile, accessible and affordable.”

About JSS University
Jagadguru Sri Shivarathreeswara University, also known by the abbreviation JSS University, is a deemed university located in the city of Mysore, in the Indian state of Karnataka. It was established in 2008 under Section 3 of the UGC Act 1956 and is part of JSS Mahavidyapeetha, which runs a variety of educational institutions. JSS University is focused on medical and health-related studies, and comprises JSS Medical College, JSS Dental College and JSS College of Pharmacy at the main campus in Mysore as well as a second pharmacy college in Ootacamund, in the neighboring state of Tamil Nadu.

About iMedrix
iMedrix is a Mobile Health startup out of Silicon Valley and Bangalore. iMedrix’s initial product, KardioScreen, is a game changer in Internet of Things Mobile Health (mHealth). 1000s of patients have been screened for heart disease using KardioScreen, often detecting life threatening conditions early on.

Contact:
Nagesh Rangappan
CTO
nagesh.r@imedrix.com
Srikanth (Sree) Jadcherla
CEO
srikanth.j@imedrix.com

1525 McCarthy Blvd
Milpitas CA 95035 USA
+1-408-637-1881

Previous Post

Thermo Fisher Scientific and Illumina Sign Agreement to Provide Research Market Broader Access to Ion AmpliSeq Technology

Next Post

BeiGene and Boehringer Ingelheim Announce Commercial Supply Agreement for Anti-PD-1 Antibody Tislelizumab

Related Posts

FDA Accepts BLA for Recommended
FDA Approvals

FDA Accepts BLA for Recommended Biosimilar to Simponi

22nd July 2025
Merck to Acquire Verona
Drug Development

Merck to Acquire Verona Pharma in $10B Deal Boosts COPD Drug

21st July 2025
ChiRhoClin LogiCare3PL Partners for Drug Distribution
News

ChiRhoClin, LogiCare3PL Partners for Drug Distribution

21st July 2025
Thermo Fisher and Sanofi Partners
Manufacturing

Thermo Fisher and Sanofi Partners for US Drug Manufacturing

21st July 2025
EMA Recommendations to Secure Anti D Immunoglobulins Supply
News

EMA Recommendations to Secure Anti-D Immunoglobulins Supply

15th July 2025
FDA Approves Oral Therapy for Treating Hereditary Angioedema
FDA Approvals

FDA Approves Oral Therapy for Treating Hereditary Angioedema

15th July 2025
Next Post

BeiGene and Boehringer Ingelheim Announce Commercial Supply Agreement for Anti-PD-1 Antibody Tislelizumab

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In